Jul 16, 2025 08:17AM
Jul 16, 2025 08:17AM
Jun 11, 2025 11:30AM
Jun 11, 2025 11:30AM
Jun 11, 2025 11:30AM
May 22, 2025 04:51PM
May 22, 2025 04:50PM Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Apr 30, 2025 06:13PM
Apr 30, 2025 06:13PM
Apr 8, 2025 08:32AM
Apr 8, 2025 08:30AM
Apr 8, 2025 08:30AM
Apr 8, 2025 08:30AM
Mar 24, 2025 08:46AM Onconetix (ONCO) Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
Mar 24, 2025 08:45AM
Mar 19, 2025 08:00AM
Dec 12, 2024 05:00PM
Dec 12, 2024 05:00PM
Oct 3, 2024 04:45PM
Oct 3, 2024 09:07AM
Oct 3, 2024 09:05AM Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
Sep 20, 2024 11:45AM
Sep 20, 2024 11:45AM
Jul 15, 2024 06:00AM
Jul 11, 2024 08:17AM
Jul 11, 2024 08:17AM
Feb 13, 2024 06:03AM
Feb 13, 2024 06:00AM Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors
Dec 18, 2023 07:03AM
Dec 18, 2023 07:00AM
Jan 18, 2023 02:14AM
Jan 11, 2023 07:51AM
Jan 4, 2023 03:24AM
Dec 22, 2022 10:16AM
Dec 12, 2022 09:42AM Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH
Dec 7, 2022 08:05AM
Nov 25, 2022 12:15PM
Oct 26, 2022 02:29AM
Sep 23, 2022 02:21AM
Sep 20, 2022 10:21AM
Jul 20, 2022 09:34AM
Jun 23, 2022 12:06PM CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma
Apr 21, 2022 04:17AM
Feb 17, 2022 02:21AM
Jan 21, 2022 03:42PM
Nov 24, 2021 02:57AM
Oct 22, 2021 09:33AM
Oct 15, 2021 11:49AM
Sep 11, 2021 08:34AM Oncopeptides presents phase 3 OCEAN study results at the IMW meeting
Sep 2, 2021 11:45AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All